Pfizer: Booster shots were 95.6% effective in Phase 3 trials
Pfizer noted that a portion of the trial took place while the spread of the more contagious delta variant was prevalent.
Stay updated with breaking news from Albert Bourlam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer noted that a portion of the trial took place while the spread of the more contagious delta variant was prevalent.
Pfizer noted that a portion of the trial took place while the spread of the more contagious delta variant was prevalent.
Pfizer noted that a portion of the trial took place while the spread of the more contagious delta variant was prevalent.
Pfizer noted that a portion of the trial took place while the spread of the more contagious delta variant was prevalent.
Pfizer noted that a portion of the trial took place while the spread of the more contagious delta variant was prevalent.